Advancing pharmacy practice through specialized board certification in biologics and biosimilars: Implications and Opportunities
1 Howard University College of Pharmacy, 2300 4th St NW, Washington, DC 20059.
2 Bristol Myers Squibb - 3551 Lawrenceville Rd, Lawrence Township, NJ 08648.
3 Department of Clinical and Administrative Pharmacy Sciences, Career Development Manager, Office of Student Affairs, Howard University College of Pharmacy, 2300 4th St NW, Washington, DC 20059.
Review
International Journal of Scholarly Research in Biology and Pharmacy, 2025, 06(01), 030-032.
Article DOI: 10.56781/ijsrbp.2025.6.1.0022
Publication history:
Received on 25 June 2025; revised on 02 August 2025; accepted on 05 August 2025
Abstract:
Purpose: The emergence of specialized board certifications, such as the Board-Certified Biologics and Biosimilars Specialist (BCBBS), represents a transformative opportunity in pharmacy practice. This paper explores the impact of such certifications on patient care and the evolving pharmaceutical landscape.
Summary: With increasing use of biologics and biosimilars, pharmacists equipped with certification are positioned to enhance patient outcomes, implement safer protocols, and close knowledge gaps in healthcare delivery. The introduction of BCBBS by the Accreditation Council for Medical Affairs (ACMA) offers specialized pharmacists training to manage complex therapies. The article reviews the broader implications of certification including improved interprofessional collaboration, enhanced pharmacist authority in care teams, and better clinical outcomes. Key challenges, such as payer restrictions, patent law barriers, and knowledge deficits, are also examined.
Conclusion: Board certification in biologics and biosimilars is a valuable advancement in pharmaceutical education and healthcare delivery. Pharmacists with specialized training can serve as leaders in biosimilar implementation, cost containment, and equitable patient care.
Keywords:
Board Certification; Pharmacists; Biologics; Biosimilars; Pharmacy Practice; Patient Care; Healthcare Delivery; Accreditation Council for Medical Affairs; BCBBS; Pharmaceutical Education
Full text article in PDF:
Copyright information:
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0